Yosra Hasni

Yosra Hasni

Auto-generated profile, based on publicly available information

Yosra Hasni

Faculty of Medicine of Sousse, Department of Endocrinology, University Hospital Farhat Hached, University of Sousse, Sousse, Tunisia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Endocrine Journal
Verified
Journal Article
Closed access
PDF file
Ach TaiebAch Taieb
Ach Taieb
HYHasni Yosra
Hasni Yosra
JMJihene Maatoug
Jihene Maatoug
BABen Abdelkarim Asma
Ben Abdelkarim Asma
KMKacem Maha
Kacem Maha
KAKoussay Ach
Koussay Ach
Diagnosis of adrenal insufficiency requires evaluation by dynamic stimulation tests. The insulin tolerance test (ITT) is accepted as the gold-standard test for the evaluation of hypothalamo-pituitary-adrenal (HPA) axis but the test is unpleasant and dangerous. Although it takes more time, glucagon stimulation test (GST) is a good alternative to ITT. The primary aim of this study was to compare the ITT and GSTs in the evaluation of HPA axe in patients with pituitary disorders. We conducted a prospective study in which ITT and GST were performed within 7 days in 81 patients. Serum cortisol was measured. We divided our population in Group 1 (G1): Adrenal Insufficiency (Peak cortisol under ITT 200 ng/mL). Receiver-operating characteristic (ROC) analysis was performed to identify the thresholds for GST. The mean peak of cortisol under GST was not significantly different from that obtained after ITT in the whole cohort (182.67 +/- 89.07 ng/mL vs. 179.75 +/- 79.01 ng/mL), and it was significantly reduced in patients of G1 (p < 10(-3)). ROC curve analysis showed that the best diagnostic accuracy was obtained with a peak cortisol cut-off to GST of 167 ng/int, (sensitivity, 89%; specificity, 79%). Using this cut-off, 86.4% of the patients were correctly classified. In our prospective series, GST is a potential accurate and safe alternative test for the assessment HPA. Test-specific cut-offs should be applied to avoid misinterpretation.

28 January 2019 in American Journal of Men's Health
Verified
Journal Article
Open access
YHYosra Hasni
Yosra Hasni
SBSabrine Bachrouch
Sabrine Bachrouch
MMMohamed Mahjoub
Mohamed Mahjoub
AMAmel Maaroufi
Amel Maaroufi
SRSonia Rouatbi
Sonia Rouatbi
Helmi Ben SaadHelmi Ben Saad
Helmi Ben Saad
Studies evaluating the metabolic profiles of ENSs are scarce and presented controversial conclusions. This study aimed to compare the metabolic profiles of ENSs’ and AHNSs’ groups. Males aged 25–45 years and free from a known history of metabolic and/or cardiovascular diseases were included. According to the smoking status, two groups of ENSs and AHNSs were identified. Body mass index (BMI, kg/m2), waist circumference (WC, cm), systolic and diastolic blood pressures (SBP, DBP, mmHg), fasting blood data in mmol/L (blood glycemia [FBG], triglycerides [TG], total cholesterol [TC], high- and low- density lipoprotein cholesterol [HDL-C, LDL-C]) and obesity status were evaluated. The metabolic syndrome (MetS) was defined according to the 2006 International Diabetes Federation (IDF) recommendations. Data were expressed as mean ± standard deviation ( SD) or percentages. Compared to the AHNSs’ group ( n = 29), the ENSs’ one ( n = 29) had (a) higher values of BMI (26.5 ± 2.3 vs. 28.2 ± 3.6), WC (95 ± 7 vs. 100 ± 10), and TG (1.22 ± 0.40 vs. 1.87 ± 0.85); and (b) included a lower percentage of males having low HDL-C (82.7% vs. 62.0%), and higher percentages of males having obesity (6.9% vs. 37.9%) or hypertriglyceridemia (10.7% vs. 51.7%). Both the ENSs’ and AHNSs’ groups: (a) had similar values of FBG (5.38 ± 0.58 vs. 5.60 ± 0.37), TC (4.87 ± 1.16 vs. 4.36 ± 0.74), HDL-C (0.92 ± 0.30 vs. 0.82 ± 0.21), LDL-C (3.09 ± 0.98 vs. 2.92 ± 0.77), SBP (117 ± 9 vs. 115 ± 8), and DBP (76 ± 6 vs. 73 ± 7); and (b) included similar percentages of males having normal weight (17.2% vs. 31.0%); overweight (44.8% vs. 62.1%); android obesity (79.3% vs. 59.6%), hypertension (10.3% vs. 10.3%), hyperglycemia (37.9% vs. 48.2%), and MetS (51.7% vs. 34.5%). There is a need to monitor narghile use among male metabolic patients since it alters some components of the MetS.

15 April 2018 in Case Reports in Dentistry
Verified
Journal Article
Open access
PDF file
NMNour Mellouli
Nour Mellouli
RCRaouaa Belkacem Chebil
Raouaa Belkacem Chebil
MDMarwa Darej
Marwa Darej
YHYosra Hasni
Yosra Hasni
LOLamia Oualha
Lamia Oualha
DNDouki Nabiha
Douki Nabiha
Introduction. Brown tumors of hyperparathyroidism are locally destructive bone lesions. They are the late clinical consequence of the disease. They can occur in primary, secondary, and rarely tertiary forms. They affect usually long bones and less frequently those of the maxilla. Case Report. Our 45-year-old female patient presented with a mandibular tumor next to the first right lower molar. At first, we have chosen tooth extraction and tumor excision. When the histological report showed the giant cell tumor we suspected a metabolic bone disorder. Biochemical tests screened hyperparathyroidism and severe vitamin D deficiency, and parathyroid scintiscan revealed parathyroid adenoma. Discussion. The association of hyperparathyroidism and vitamin D deficiency leads to diagnostic uncertainty. First, secondary hyperparathyroidism can be due vitamin D deficiency. Second, data available show that vitamin D deficiency is more prevalent in patients with primary hyperparathyroidism than in general population. Hyperparathyroidism management is based on correct and precise diagnosis. Furthermore, the resolution of brown tumors depends on the cure of hyperparathyroidism. In fact, bone lesions should regress after biological tests’ normalization. Conclusion. Clinicians should be aware of such rare and complicated presentation. They must consider the diagnosis of the brown tumor to avoid extensive surgical excision and teeth extractions.

1 January 2018 in Pan African Medical Journal
Verified
Journal Article
Open access
Ach TaiebAch Taieb
Ach Taieb
ACAsma Ben Cheikh
Asma Ben Cheikh
YHYosra Hasni
Yosra Hasni
AMAmel Maaroufi
Amel Maaroufi
MKMaha Kacem
Maha Kacem
KAKoussay Ach
Koussay Ach
La c?tose est une complication aigu? du diab?te qui consiste en une accumulation de corps c?toniques sanguins. Malgr? la haute pr?valence du diab?te c?tosique d?crite, il existe tr?s peu d?informations concernant l??pid?miologie de cette complication inaugurale du diab?te en Tunisie. L?objectif ?tait de d?terminer les caract?ristiques ?pid?miologiques et clinico-biologiques des c?toses inaugurales dans un h?pital du Centre-Est tunisien. Il s?agit d?une ?tude r?trospective, transversale et exhaustive, ? propos de patients admis pour une c?tose inaugurale sur une p?riode allant de janvier 2010 ? ao?t 2016. La population d??tude a ?t? divis?e en 2 groupes selon la pr?sence ou pas d?une auto-immunit? anti pancr?atique: groupe DAI (diab?te de type 1 auto-immun) regroupe tous les patients avec une auto-immunit?, et le groupe DNAI (diab?te c?tosique non auto-immuns) sans auto-immunit?. Il s?agit de 391 patients, de sex ratio 266 hommes/125 femmes, d??ge moyen de 34?14,33 ans. La pr?dominance masculine ?tait nette: 68% dans la population g?n?rale. L??ge de la c?tose ?tait significativement plus pr?coce dans le groupe DAI. Un facteur pr?cipitant la c?tose ?tait retrouv? chez 77,7% de la population globale d??tude, significativement plus fr?quent dans le groupe DAI que dans le groupe DNAI. Le facteur le plus retrouv? ?tait les infections virales. Les Anticorps anti thyro?diens ?taient significativement importants dans le groupe DAI. La c?tose est un facteur de d?compensation inaugurale fr?quent du diab?te en Tunisie. La population la plus importante a ?t? d?crite chez l?adulte jeune masculin, avec l?absence d?une auto-immunit?, et un profil clinique du diab?te de type 2.

18 October 2018 in Pan African Medical Journal
Verified
Journal Article
Open access
Ach TaiebAch Taieb
Ach Taieb
YHYosra Hasni
Yosra Hasni
AAAsma Ben Abdelkarim
Asma Ben Abdelkarim
AMAmel Maaroufi
Amel Maaroufi
MKMaha Kacem
Maha Kacem
KAKoussay Ach
Koussay Ach
The influence of stress as a precipitating factor associated with the onset of type 1 diabetes have been widely studied in the literature. The relationship between physical and psychological traumas and diabetes has been rarely studied in the military environment. Posttraumatic diabetes is a controversial topic. We here report the case of a Tunisian soldier, with no previous medical and family history of autoimmune disease who was diagnosed with Type 1 diabetes after a physical aggression occurred during a social conflict between the forces of law and order and the citizens.

30 September 2020 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
RAR. Ajili
R. Ajili
GSG. Saad
G. Saad
AGA. Gorchène
A. Gorchène
AAA. Ben Abdelkarim
A. Ben Abdelkarim
YHY. Hasni
Y. Hasni
KAK. Ach
K. Ach